|

Everolimus 10 mg Clinical Trials

2 actively recruiting trials

▼ -1 trial since August 2026

Also known as: Afinitor, CapOx/GemOx

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Fudan University1
  • Forward Pharmaceuticals Co., Ltd.1

Indications

  • Breast Cancer2
  • Cancer2
  • Locally Advanced Breast Cancer (LABC)1
  • ER+ Breast Cancer1
  • Breast Cancer Stage II1

Other2 trials

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Phase 1/2
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.